ANNUAL REPORT 2012
TRANSFORMING LIVES
Enhancing Care
Championing Cord Blood Bank
Researching Possibilities
Upgrading Knowledge
VISION To realise tomorrow’s medicine.
MISSION To facilitate medical innovation for better healthcare.
CONTENTS 01 02 03 04 05 06 07 22 24 IBC*
Chairman’s Message Structure, Management and Governance Championing Cord Blood Bank Upgrading Knowledge Researching Possibilities Enhancing Care Financial Highlights, Statements and Reports List of Projects Approved for Funding in FY2012 Programme Highlights for FY2012 Donors, Partners and Supporters
*Inside Back Cover
SingHealth Foundation Annual Report 2012 01
CHAIRMAN’S MESSAGE
SingHealth Foundation was established in 2002 as a non-profit grantmaking organisation whose purpose is to manage funds donated in support of medical research, upgrading the skills of our healthcare professionals and improving the quality and accessibility of healthcare services – ultimately transforming patients’ lives. In FY2012, we continued to make strides in our endeavours with the generous support of our partners and donors. As an institution of Public Character (IPC) under the Ministry of Health, we abide by the Code of Governance for Charities and Institutions of Public Character with respect to governance, grant administration and fundraising activities. Beyond complying with regulatory requirements, we continually look for ways to improve the processes and procedures for managing grants and donor funds. With over $158.3 million in general and earmarked funds under our purview, governance and financial management practices remain crucial to our operations. We strive to efficiently manage our funds including the endowment funds of four SingHealth institutions: Singapore General Hospital, National Heart Centre Singapore, National Dental Centre and, until February 2013, Changi General Hospital. Indeed, the Foundation continues to attract donations and garner donor confidence on the use of funds based on the strength of our governance structure. Our grants are an investment into the continued advancement of healthcare standards for the benefit of Singapore’s future generations. To this end, we have further defined our four core focus areas – Championing Cord Blood Bank, Upgrading Knowledge, Researching Possibilities and Enhancing Care, or “CURE” – which combine to deliver optimal healthcare for Singapore. Our current priority is to support through our grants SingHealth’s strategic drive towards academic medicine and Singapore’s overall drive towards community healthcare and improved access to healthcare. SingHealth Foundation funded 17 new programmes within the four core areas of focus for FY2012, bringing our total programmes to 83. Through new grants and ongoing programmes, the Foundation supported almost 1,400 scholarships and research projects in the SingHealth Cluster; provided aid to over 2,000 needy patients; continued to provide platforms for better healthcare and health education; and continued to support the Cord Blood Bank as it provides needed stem cells to save lives.
Together, with your continued partnership and support in this charitable endeavour, we can make sustained improvements in the health of our communities by encouraging and supporting those programmes that allow medical and healthcare professionals to deliver ever more impactful healthcare services.
We thrive on facilitating partnerships between the healthcare industry and companies, institutions and like-minded individuals. Funds have been wisely invested in supporting critical programmes that facilitate integration of care in the community so that patients receive seamless, high quality care; programmes that allow our healthcare professionals to expand their knowledge and skills for improved patient care; and research that points the way to the future of medicine. As always, the Foundation’s performance in FY2012 was fuelled by the commitment of our dedicated Board of Trustees whom I would like to sincerely thank for their counsel and guidance. Our heartfelt thanks also go to SingHealth Foundation’s generous donors and partners for their significant contributions and support.
Prof Tan Ser Kiat Chairman SingHealth Foundation
02 SingHealth Foundation Annual Report 2012
STRUCTURE, MANAGEMENT AND GOVERNANCE
SingHealth Foundation was established in 2002 as a non-profit grantmaking organisation. The Foundation is an Institution of Public Character (IPC) under the supervision of the Ministry of Health, which acts as the Central Fund Administrator.
Board of Trustees The Foundation is governed by a Board of Trustees comprising talented and respected individuals from the medical, healthcare business, and philanthropic communities. They provide extensive knowledge and strong corporate stewardship and are passionate about strengthening the future of healthcare provision in Singapore. The Board of Trustees oversees and approves the formulation of the Foundation’s strategic objectives and directions, and sets the values and standards of the Foundation. The Board of Trustees also reviews the Foundation’s activities, adequacy of internal controls, financial reporting and compliance, as well as management performance.
Policies and Procedures The Foundation has incorporated policies and procedures to ensure that the requirements for Institutes of Public Character (IPCs) are met. Investment, Purchasing, Media and Communications, Grantmaking and Conflict of Interest policies have been established. The overriding rules and regulations of the Foundation, including board governance, fundraising and other operating requirements presented in the Foundation’s Operating Rules, reflect the current regulatory requirements. The Board of Trustees reviews policies and procedures regularly to ensure that these policies remain relevant, effective and contributory to preserving the trust and confidence of our stakeholders.
BOARD OF TRUSTEES
OCCUPATION
DATE OF APPOINTMENT
Prof Tan Ser Kiat (Chairman)
Orthopaedic Surgeon / Emeritus Consultant (Singapore Health Services Pte Ltd)
20 June 2002
Mr Johnny Quah (Honorary Treasurer)
Chief Financial Officer (Singapore Health Services Pte Ltd)
1 May 2010
Prof Ivy Ng
Paediatrician / Group CEO (Singapore Health Services Pte Ltd)
1 July 2008
Mr Alexander Chan
Company Director
31 March 2011
Ms Stacy Choong
Lawyer
1 May 2010
A/Prof Lim Lean Huat
Medical Doctor
1 May 2010
Dr Low Lip Ping
Cardiologist
1 May 2010
Conflict of Interests
Mr Siow Chai Sheng
Company Director
1 March 2012
Mr Phillip Tan
Company Director
1 May 2010
Mrs Teo Poh Yim
Company Director
15 July 2009
The Foundation maintains a Conflict of Interests policy to assist the Board of Trustees, employees, consultants, vendors, volunteers, and major donors of the Foundation to identify and manage situations that may present potential conflicts of interest. The policy includes requirements for the declaration of potential conflicts, procedures for managing such conflicts, and documentation required if such conflicts occur.
Governance The Board of Trustees and Management of the Foundation are committed to maintaining high standards of governance and abide by the Code of Governance for Charities and Institutions of Public Character. The Foundation believes that its governance practices are in line with the principles of the regulations. New governance practices are implemented on a timely basis throughout the financial year.
Audit Committee The Audit Committee comprises three Trustees. The Audit Committee is chaired by Mr Phillip Tan who was appointed on 18 May 2010. During the year under review, the Committee met and completed the following: Reviewed the results of the external audit and recommended to the Board of Trustees the approval of audited financial statements. Considered and approved the Audit Strategy and Planning Memorandum for both external and grant audits.
Grantmaking Committee
Reserve Policy The Foundation maintains reserves to fund its current and committed obligations in order to meet the goals and mission of the organisation. Reserves include funds designated for grants.
Management
The Grantmaking Committee is chaired by Dr Low Lip Ping who was appointed on 18 May 2010. During the year under review, the Committee met twice to make recommendations to the Board of Trustees on grant awards. The Committee also measures the effectiveness of the grantmaking programme and develops grantmaking criteria for the Foundation.
The Executive Director and the General Manager have been given the responsibilities of implementing policies and directions laid down by the Board of Trustees.
Investment Committee
The Executive Director volunteers his service to the Foundation.
The Investment Committee was established in December 2011. The Committee is chaired by Mr Johnny Quah who was appointed on 6 December 2011. The Committee recommends investments and investment policy to the Board of Trustees in keeping with the investment objectives of the Foundation. The Committee establishes and reviews the strategy and investment process to ensure that the investment objectives of the Foundation are met.
Dr Kwa Chong Teck has served as Executive Director since 29 March 2004. Ms Nancy Frohman has served as General Manager since 1 September 2005.
SingHealth Foundation Annual Report 2012 03
CHAMPIONING CORD BLOOD BANK When it comes to matching cord blood with patients requiring life-saving blood stem cell transplants, ethnicity matters. As the first public cord blood bank in Southeast Asia, the Singapore Cord Blood Bank (SCBB) improves the chances of Asian patients finding a suitable cord blood unit (CBU) match, increasing their chances of survival. Fulfilling a social mission
Building a safe, high-quality inventory
It is estimated that 65 to 80% of Asian patients worldwide are unable to find a suitable cord blood stem cell match to treat their medical conditions due to a lack of donors of Asian lineage. With only a one in four chance of a match amongst siblings, patients would soon succumb to their diseases should this life-saving resource be unavailable.
With the effort and support of cord blood donors and other key stakeholders such as healthcare professionals, SCBB has now attained 96% of its initial targeted inventory of 10,000 high-quality and clinically safe CBUs, with 9,681 CBUs banked to date.
The SCBB fulfills a social mission of facilitating life-saving transplants by storing cord blood obtained from donors predominantly of Asian lineage. These donors contribute to a growing unique Asian inventory, thereby raising the probability of needy Asian patients finding a match. In FY2012, almost 12% of parents donated their babies’ cord blood to the SCBB – an increase from 7% in 2010. The growing awareness of cord blood donation among expectant parents contributed to the higher numbers. One such parent, Mr Kelvin Chan and his wife chose to donate their child’s cord blood after understanding their cord blood banking options. “We found that the use of cord blood for autologous therapy is very limited. Thus, we decided to donate our child’s cord blood to the public cord blood bank so that the benefits of cord blood can be utilised for the greater good of providing an increased chance of a patient finding a match.”
As one of the few public cord blood banks in the world specifically amassing Asian cord blood units, SCBB has facilitated in 126 unrelated cord blood transplants from its donated Cord Blood Inventory. Since its first cord blood transplant five years ago, SCBB has conducted over 990 searches and has made substantial progress by facilitating unrelated blood stem cell transplants for 49 children and 77 adults for whom no suitable matches were found from alternative sources. Time is of the essence when finding a stem cell match and transporting the cord blood units to the transplant destination. SCBB’s status as a full AABB (formerly known as American Association of Blood Banks) Accredited Cord Blood Bank and a member of NMDP (National Marrow Donor Program) enables the shipping of cord blood units to the USA to be shortened as it does not require special handling or clearance, reflecting the quality and professionalism of SCBB. SCBB remains the only fully AABB-accredited public cord blood bank in Singapore and in Southeast Asia, a testament to its dedication and commitment to high safety standards and the quality of the cord blood units banked.
Facilitating transplants for blood cancer and blood disorder patients Out of 28 medical conditions that the SCBB has helped to facilitate blood stem cell transplants for, half of them are for blood disorders, the other half are for blood cancers, the two most common forms of blood cancer being acute lymphocytic leukemia and acute myeloid leukemia. These transplants have helped 91% of adults and 53% of children being treated for blood cancer, as well as 80% of children being treated for blood disorders.
04 SingHealth Foundation Annual Report 2012
UPGRADING KNOWLEDGE SingHealth Foundation is committed to the ongoing training and development of our healthcare professionals. We support programmes that provide them with the right opportunities to grow all round as clinicians, researchers and teachers, contributing to SingHealth’s transformation into an Academic Medical Centre, while upholding the highest standards of patient care. Skills Development Programmes In FY2012, there were a total of 33 main programmes, including 7 approved during the financial year and 26 programmes carried on between FY2005-FY2011, totalling over $98m as at March 2013. These included the: Talent Development Fund, which saw almost 6,000 staff trained through educational trips, conferences, workshops, congresses, faculty development and residency programmes, including over 60 Bachelor’s, 30 Master’s and 3 PhD degrees. Training/Upgrading of Nursing Personnel programmes, which tapped on earmarked funds from Lee Foundation to equip nurses to take on leadership roles. 47 nurses were awarded scholarships to pursue Bachelor’s, Master’s and PhD programmes, of which 35 completed their studies from FY2008-FY2012. All nurses have since completed their courses and are now contributing their learning to their respective departments.
Academic Clinical Programmes SingHealth Foundation funds Academic Clinical Programmes that support SingHealth and Duke-NUS’ shared vision to transform the culture of hospitals from being merely service providers into academic medical centres that combine clinical care with education and research, leading to improved patient care. Academic Medicine aims to train the next generation of healthcare professionals to become not only better clinicians, but tap into their potential to become great researchers and educators too. Clinicians working across different disciplines have the opportunity to identify and address unmet needs. Through research, they have the potential to produce clinical breakthroughs that lead to new and better treatments. At the Academic Medicine Education Institute, doctors, nurses and allied health workers are exposed to innovative teaching methods that motivate and equip them to become better teachers. Such a dynamic, patient-care driven environment also attracts and retains top talent. The Academic Clinical Programme (ACP) is a cluster-wide framework for all clinical specialties to advance in Academic Medicine. Since inception, nine ACPs have been rolled out across different clinical disciplines. Each ACP brings together all specialists in the discipline across various institutions for greater synergies in clinical care, education and research. Through ACP, patients have already benefited from research and care innovations such as the world’s first free mobile app launched by SNEC to help glaucoma patients apply their eye drops, and a virtual supermarket game developed by SGH as therapy to help stroke patients strengthen their limbs and regain their balance.
The Alice Lee (IAN) scholarship to pursue the Doctor of Philosophy in Nursing is the fourth sponsorship I have received in my nursing career. I was holding the ‘Quality Management and Nursing Research’ portfolio and, hence, the PhD was highly relevant to my work. I am now a DDN providing oversight to the Nurses Development Unit, Simulation Centre and Research. I apply the lessons I gained as a PhD student into the training programmes that I develop. Last year, I received the SingHealth-Duke-NUS Golden Apple Award for the Most Outstanding Creative Educator Award. This year, two programmes that I have planned are in progress and already receiving excellent reviews. Ms. Chia Yen Yen Deputy Director, Nursing KK Women’s and Children’s Hospital FY2005 Recipient of IAN scholarship (PhD)
I believe in training, up-skilling and enhancing competencies so that all nurses can perform optimal patient care. Education is a life-long process. Undertaking research at PhD level not only enabled me to gain valuable new knowledge but also trained me to look at problems and find solutions in a new manner. Ms. Tan Siok Bee Assistant Director, Nursing (APN) Singapore General Hospital, Nursing Clinician, Specialty Care Services FY2006 Recipient of IAN scholarship (PhD)
SingHealth Foundation Annual Report 2012 05
RESEARCHING POSSIBILITIES Research has the power to unlock new knowledge that can lead to timelier, safer, more efficient and more cost-effective healthcare applications. Committed to advancing the future of healthcare in Singapore, SingHealth Foundation’s support during the year has spurred research and development in areas that have the potential to improve the health of our communities and transform the next generation of care and treatment options. Novel Biomarkers for Diabetic Retinopathy Diabetic Retinopathy (DR) is a complication of diabetes that causes damage to the retina and can eventually lead to blindness. Despite affecting up to 80% of all patients who have had diabetes for 10 years or more, research indicates that at least 90% of new cases could be reduced with vigilant treatment and monitoring of the eyes. A new study aims to identify new protein molecules, or biomarkers, involved in DR which may provide a better understanding of the disease mechanism as well as aid prevention and treatment. If successful, these biomarkers could be used to detect DR early or be used in its therapy, potentially reducing blindness in a significant proportion of the diabetic population.
Aspirin as Adjuvant Therapy for Colorectal Cancer Patients Aspirin may stop the growth of tumor cells and may even slow disease progression after surgery. A new clinical trial now seeks to find out if aspirin is effective in blocking the return of colorectal cancer that has been completely removed by surgery. This international, multi-centre trial will be conducted with Dukes’ C and high-risk Dukes’ B colorectal cancer patients over a five-year period.
It will engage 38 sites in 10 countries across Asia in a major research collaboration. If the results are conclusive, it could mean that an affordable generic drug may be used as treatment or prevention of colorectal cancer.
Atropine Eye Drops in the Treatment of Childhood Myopia While atropine drops have been shown to control myopia progression, the potential side effects have often been a source of concern. A new study by the Singapore Eye Research Institute (SERI) was conducted with 400 children to compare the efficacy and visual side effects of atropine treatment in order to establish an optimal dose. Results showed that a lower dose of 0.01% concentration applied nightly provided effective control with less side effects. This has translated into potential new guidelines on the use of atropine treatment in the continued fight against myopia.
3D Computerised Software for Cognitive Evaluation and Rehabilitation Computerised cognitive evaluation offers a timely and efficient method to detect and manage cognitive impairment. However, most of the software available in the industry is not designed for the local setting – until now.
Early Childhood Oral Health Programme Although preventable, early childhood tooth decay is widespread in Singapore, affecting 40% of pre-schoolers by four years of age. A two-year study will be conducted to see if the introduction of an oral health programme in early childhood can help to reduce tooth decay in children. One group of infants enrolled in the programme will receive a comprehensive oral examination and topical fluoride treatment every six months for two years, while another group will receive a one-time standard dental consultation. Comparing the amount of tooth decay in each group at the end of the study will provide vital information on the efficacy of early preventive dental care, with the potential to shape future dental healthcare policies.
The National Neuroscience Institute (NNI) has successfully developed a prototype of a computerised three-dimensional cognitive evaluation software designed to meet the cultural and language needs of the Singapore population, providing a more valid tool for assessing patients’ cognitive abilities in real-life situations. A Mandarin version was also produced and a touchscreen version for use on tablet platforms is being explored.
06 SingHealth Foundation Annual Report 2012
ENHANCING CARE Dedicated to improving the quality of life for our patients, SingHealth Foundation supports a variety of programmes and initiatives that foster holistic, patient-centred care and provide hope and connection where it is needed most. In FY2012, 27 active programmes were funded to bring healthcare services closer to the community. Transitional Home Medical Care
Mr. CCS Mr. CCS is a 78-year-old Chinese male with a medical history of strokes, diabetes mellitus and ischaemic heart disease. He was readmitted within two weeks after he was discharged from initial hospitalisation. He was identified and referred to the THMC team for home medical care as it was difficult to bring him for hospital appointments due to his inability to manage daily self-care tasks. The THMC team visited him at home within four days of discharge, while the medical and nurse team dealt with the care issues that arose during regular follow-up visits. As his family was in financial need, THMC funds were tapped on to purchase a subsidised hospital bed and commode. A physiotherapist and speech therapist from SGH were engaged to provide home treatment and evaluation. The team also engaged community partners for home help to reduce caregiver burden and stress. Since being cared for on the programme, Mr. CCS has had no readmissions for the past four months.
The transition from hospital to home can be a difficult time for disabled or elderly patients and their families due to the complexity of care required. The Transitional Home Medical Care (THMC) programme seeks to reduce avoidable hospital readmissions by better integrating services among transitional care providers such as community hospitals, polyclinics, and other community-based physicians and organisations. Under the THMC programme, the inpatient team identifies patients at a higher risk for readmissions, particularly the very elderly or patients with complex medical and social needs, and customises a personalised and family-centred approach to home care. This involves tailoring care to the abilities and changing needs of each patient while empowering patients and their caregivers to make informed decisions concerning care. The team is ideally placed to holistically manage a significant proportion of subacute medical problems at home, identify medical problems and intervene early, and communicate with any referring departments and allied medical partners. Revamped in 2012, this initiative has successfully lowered readmissions by ensuring smooth transitions along the care continuum.
Transformation, Redevelopment and Reorganisation of SingHealth Polyclinics In line with the Ministry of Health and SingHealth’s strategy to develop a patient-centric healthcare system, the Foundation supported the Transformation, Redevelopment and Reorganisation of SingHealth Polyclinics – Bedok, Geylang and Tampines to improve patient access to more health services in care settings which are most appropriate for their condition. SingHealth Geylang polyclinic underwent renovation and reopened with a host of new elder- and wheelchair-friendly features including: low-height counters for easier communication with counter staff; more spacious waiting areas; handrails fitted along corridors; large, easier-to-read signs; armrest supports on all chairs; as well as related clinical services relocated closer to each other. The clinic also boasts two firsts for a SingHealth polyclinic – a new Geriatric Centre that manages elderly patients with conditions such as osteoporosis and dementia, and the achievement of the BCA Green Mark Gold Award for its environmental design and performance measures.
SERI Ocular Imaging Centre Streamlines Screening In line with the Ministry of Health’s recommendation to screen for Diabetic Retinopathy (DR) at national level, the Singapore Eye Research Institute has established an Ocular Imaging Centre (OIC), which has enabled centralised DR screening to be implemented in SingHealth polyclinics. Images taken at polyclinics are transmitted to the OIC via a dedicated web-based teleopthamology platform, where images are graded and results are transmitted back to the polyclinics. As a result, patients can now receive their reports and any referrals within an hour, compared to one to four weeks previously. So far, the OIC has screened 18,417 patients with a current referral rate of 24%, significantly less than the previous rate of 38%.
SingHealth Foundation Annual Report 2012 07
FINANCIAL HIGHLIGHTS, STATEMENTS AND REPORTS STATEMENTS AND REPORTS
ed t a ul und ) m F LI O N cu L c MI A 3 . 8 5 ($1
13%
Surplus Fund
38%
Committed Fund
49%
Restricted Fund
1. Surplus Funds are used for operating and future grant commitment. 2. Committed Funds are multi-year commitments which have been approved for disbursement FY2013-FY2015. 3. Restricted Funds are designated by donors for specific causes. Restricted and Committed Funds represent 87% of total funds for the year. 4. As of Fiscal Year 2012, Surplus Funds/Operating Expenditure ratio is 18.8. 5. As of Fiscal Year 2012, Operating Expenditure/Funds ratio is 0.69%.
Fundraising Expenses
1%
Operating Expenses
4%
Grant Expenses
77%
Other Expenses (Distribution)
18%
An of nua lU (M Fu n I LL s d IO s es NS )
In Fiscal Year 2012, 77% of the total expenditure channelled to grant giving.
t an n r G io at c o All
3%
Championing Cord Blood Bank
60%
Upgrading Knowledge
27%
Researching Possibilities
10%
Enhancing Care
08 SingHealth Foundation Annual Report 2012
STATEMENT OF TRUSTEES We, Prof Tan Ser Kiat and Quah Seng Huat Johnny, on behalf of the Board of Trustees of SingHealth Foundation (“Foundation”), do hereby state that in our opinion: (a) the accompanying financial statements as set out on pages 10 to 21 are drawn up in accordance with the Charities Accounting Standards, and provisions under Regulation 16 of the Charities (Institutions of a Public Character) Regulations of the Charities Act, Cap. 37 (the “Act”) so as to give a true and fair view of the state of affairs of SingHealth Foundation (the “Foundation”) as at 31 March 2013, and of the results, changes in fund and cash flows of the Foundation for the year then ended; (b) the total relevant fundraising expenses did not exceed 30% of the total relevant receipts from fundraising and sponsorships for the year as prescribed in Regulation 15 of the Charities (Institutions of a Public Character) (Amendment) Regulations 2008 of the Charities Act, Cap. 37; and (c) the accounting and other records required by the Acts have been properly kept in accordance with the provisions of the Acts.
APPROVED BY THE BOARD OF TRUSTEES AND SIGNED ON BEHALF OF THE TRUSTEES
Prof Tan Ser Kiat
Date: 10 September 2013
Quah Seng Huat Johnny
SingHealth Foundation Annual Report 2012 09
INDEPENDENT AUDITORS’ REPORT Report on the Financial Statements We have audited the accompanying financial statements of SingHealth Foundation (the “Foundation”), which comprise the balance sheet as at 31 March 2013, statement of financial activities and statement of cash flows of the Foundation for the year then ended, and a summary of significant accounting policies and other explanatory information as set out on pages 10 to 21.
Management’s Responsibility for the Financial Statements Management is responsible for the preparation of financial statements that give a true and fair view in accordance with the provisions of the Charities Act, Cap. 37 (the “Act”) and Charities Accounting Standards, and for devising and maintaining a system of internal accounting controls sufficient to provide reasonable assurance that assets are safeguarded against loss from unauthorised use or disposition; and transactions are properly authorised and that they are recorded as necessary to permit the preparation of true and fair profit and loss account and balance sheet and to maintain accountability of assets.
Auditors’ Responsibility Our responsibility is to express an opinion on these financial statements based on our audit. We conducted our audit in accordance with Singapore Standards on Auditing. Those standards require that we comply with ethical requirements and plan and perform the audit to obtain reasonable assurance about whether the financial statements are free from material misstatement. An audit involves performing procedures to obtain audit evidence about the amounts and disclosures in the financial statements. The procedures selected depend on the auditor’s judgement, including the assessment of the risks of material misstatement of the financial statements, whether due to fraud or error. In making those risk assessments, the auditor considers internal control relevant to the entity’s preparation of financial statements that give a true and fair view in order to design audit procedures that are appropriate in the circumstances, but not for the purpose of expressing an opinion on the effectiveness of the entity’s internal control. An audit also includes evaluating the appropriateness of accounting policies used and the reasonableness of accounting estimates made by management, as well as evaluating the overall presentation of the financial statements. We believe that the audit evidence we have obtained is sufficient and appropriate to provide a basis for our audit opinion.
Opinion In our opinion, the financial statements are properly drawn up in accordance with the provisions of the Act and Charities Accounting Standards so as to give a true and fair view of the state of affairs of the Foundation as at 31 March 2013 and the results and cash flows of the Foundation for the year ended on that date.
Report on Other Legal and Regulatory Requirements In our opinion, the accounting and other records required by the Act to be kept by the Foundation have been properly kept in accordance with the provisions of the Act. During the course of our audit, nothing has come to our attention that causes us to believe that during the year: (a) The use of the donation monies was not in accordance with the objectives of the Foundation as required under Regulation 16 of the Charities (Institutions of a Public Character) Regulations; and (b) The Foundation has not complied with the requirements of Regulation 15 (Fundraising expenses) of the Charities (Institutions of a Public Character) Regulations.
Public Accountants and Chartered Accountants Singapore
Date: 10 September 2013
10 SingHealth Foundation Annual Report 2012
BALANCE SHEET
AS AT 31 MARCH 2013
Note
2013
2012
$
$
ASSETS Non-current assets Equipment
6
12,090
26,580
Donations receivable
8
24,000,000
34,000,000
24,012,090
34,026,580
Total non-current assets Current assets Cash and cash equivalents
7
130,327,431
141,832,076
Donations receivable
8
10,684,595
5,286,774
Other receivables
9
337,753
287,296
Total current assets
141,349,779
147,406,146
Total assets
165,361,869
181,432,726
FUNDS AND LIABILITY Funds of the Foundation Restricted funds
11
124,002,535
131,074,668
Unrestricted funds
11
34,268,823
33,225,067
158,271,358
164,299,735
7,090,511
17,132,991
7,090,511
17,132,991
165,361,869
181,432,726
Current liability Trade and other payables Total liability Total funds and liability
The accompanying notes form an integral part of these financial statements.
10
SingHealth Foundation Annual Report 2012 11
STATEMENT OF FINANCIAL ACTIVITIES
YEAR ENDED 31 MARCH 2013
2013
2012
Note Unrestricted funds
Restricted funds
Total funds
Unrestricted funds
Restricted funds
Total funds
$
$
$
$
$
$
9,980,532
6,684,011
16,664,543
9,757,515
12,465,169
22,222,684
68,000
–
68,000
–
–
–
793,810
123,952
917,762
635,650
77,645
713,295
10,842,342
6,807,963
17,650,305
10,393,165
12,542,814
22,935,979
Income Income from generated funds Voluntary income
12
Other income Interest income Total income
Expenditures Cost of generating funds
13
(16,576)
161,252
144,676
308,781
88,996
397,777
Charitable activities expenses
14
9,285,047
9,217,073
18,502,120
7,354,688
17,386,153
24,740,841
Governance cost
15
530,115
56,729
586,844
509,092
45,568
554,660
Other expenditure
16
–
4,445,042
4,445,042
–
–
–
9,798,586
13,880,096
23,678,682
8,172,561
17,520,717
25,693,278
1,043,756
(7,072,133)
(6,028,377)
2,220,604
(4,977,903)
(2,757,299)
Total funds brought forward
33,225,067
131,074,668
164,299,735
31,004,463
136,052,571
167,057,034
Total funds carried forward
34,268,823
124,002,535
158,271,358
33,225,067
131,074,668
164,299,735
Total expenditures Net income (expenditure) for the year
17
Reconciliation of funds
The accompanying notes form an integral part of these financial statements.
12 SingHealth Foundation Annual Report 2012
STATEMENT OF CASH FLOWS
YEAR ENDED 31 MARCH 2013
2013
2012
$
$
(6,028,377)
(2,757,299)
(917,762)
(713,295)
14,490
27,478
Cash flows from operating activities
Net expenditure for the year (Note A)
Adjustments for:
Interest income
Depreciation of plant and equipment
Operating cash flows before movement in working capital
Donations receivable
Other receivables
Trade and other payables
(6,931,649)
(3,443,116)
4,602,179
19,796,341
(30,610)
1,098
(10,042,480)
7,105,552
(12,402,560)
23,459,875
897,915
617,873
–
(1,015)
897,915
616,858
–
60,940
Net (decrease) increase in cash and cash equivalents
(11,504,645)
24,137,673
Cash and cash equivalents at beginning of the year
141,832,076
117,694,403
Cash and cash equivalents at end of the year (Note 7)
130,327,431
141,832,076
Net cash (used in) from operating activities Cash flows from investing activities
Interest received
Purchase of equipment
Net cash from investing activities Cash flows from financing activity Government ministry grant received, representing net cash from financing activity
Note A:
Included in the net expenditure for the year a distribution to Changi Health Fund (LTD) (“CHF”) of the unused balance of donations the Foundation holds that are designated to Changi General Hospital and Eastern Health Alliance as described in Note 16.
The accompanying notes form an integral part of these financial statements.
SingHealth Foundation Annual Report 2012 13
NOTES TO THE FINANCIAL STATEMENTS
AS AT 31 MARCH 2013 1 GENERAL
The SingHealth Foundation (the “Foundation”) was established on 25 June 2002 to receive donations for and provide grants to health related programmes and services including medical, nursing, administration and health-care related education and training; biomedical research and development; programmes to improve patient-care services; and other healthcare related programmes and services.
The Foundation is registered as a Charity under the Charities Act, Cap. 37 since its establishment.
The Foundation has also been granted Institution of a Public Character (“IPC”) status since 25 June 2002. The current tax exempt status expires on 24 June 2014.
The financial statements of the Foundation are measured and presented in the currency of the primary economic environment in which the Foundation operates (its functional currency), which is the Singapore dollar.
The financial statements of the Foundation for the year ended 31 March 2013 were authorised for issue by the Board of Trustees on 10 September 2013.
2
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
BASIS OF ACCOUNTING – The financial statements are prepared in accordance with the historical cost convention, except as disclosed in the accounting policies below, and are drawn up in accordance with the provisions of the Charities Act, Cap. 37 and Charities Accounting Standards (“CAS”).
These financial statements are the Foundation’s first financial statements prepared in accordance with CAS. The financial statements for previous periods had been prepared in accordance with Singapore Financial Reporting Standards (“FRS”). There is no material impact to the financial statements of the Foundation with the adoption of CAS.
The CAS issued by Accounting Standards Council (“ASC”) sets out the basis for preparing and presenting financial statements for the charity sector and is applicable to financial periods beginning on or after 1 July 2011. The definitions and accounting treatments presented in the CAS are developed based on the requirements of FRS taking into account the context and circumstances relevant to the charity sector.
FINANCIAL INSTRUMENTS – Financial assets and financial liabilities are recognised on the Foundation’s balance sheet when the Foundation becomes a party to the contractual provisions of the instrument.
Financial assets
Donation and other receivables
Donation and other receivables are recognised at their transaction price excluding transaction costs, if any. Transaction costs are recognised as expenditure in the statement of financial activities as incurred.
After initial recognition, trade and other receivables are subsequently measured at cost less any accumulated impairment losses.
The amount of the allowance is the difference between the asset’s carrying amount and the undiscounted future cash flows, excluding unearned interest of interest-bearing assets that the Foundation expects to receive from the assets. The amount of the allowance for impairment is recognised in the statement of financial activities.
Impairment of financial assets
Financial assets are assessed for indicators of impairment at the end of each reporting period. Financial assets are impaired where there is objective evidence that, as a result of one or more events that occurred after the initial recognition of the financial asset, the estimated future cash flows of the financial assets have been impacted. In the case of trade and other receivables, the amount of impairment loss is the difference between the financial asset’s carrying amount and the undiscounted cash flows, excluding unearned interest of interest-bearing assets that the Foundation expects to receive from the assets.
The carrying amount of the financial asset is reduced by the impairment loss directly for all financial assets with the exception of trade and other receivables where the carrying amount is reduced through the use of an allowance account. When a trade or other receivable is uncollectible, it is written off against the allowance account. Subsequent recoveries of amounts previously written off are credited against the allowance amount. Changes in the carrying amount of the allowance account are recognised in profit or loss.
If, in a subsequent period, the amount of the impairment loss decreases and the decrease can be related objectively to an event occurring after the impairment loss was recognised, the previously recognised impairment loss is reversed through profit or loss to the extent the carrying amount of the financial assets at the date the impairment is reversed does not exceed what the cost would have been had the impairment not been recognised.
14 SingHealth Foundation Annual Report 2012
NOTES TO THE FINANCIAL STATEMENTS
AS AT 31 MARCH 2013
Derecognition of financial assets
The Foundation derecognises a financial asset only when the contractual rights to the cash flows from the asset expire, or it transfers the financial asset and substantially all the risks and rewards of ownership of the asset to another entity. If the Foundation neither transfers nor retains substantially all the risk and rewards of ownership and continues to control the transferred asset, the Foundation recognises its retained interest in the asset and an associated liability for amounts it may have to pay. If the Foundation retains substantially all the risks and rewards of ownership of a transferred financial asset, the Foundation continues to recognise the financial asset and also recognises a collateralised borrowing for the proceeds received.
Financial liabilities and equity instruments
Trade and other payables
Trade and other payables are recognised at their transaction price, excluding transaction costs, if any, both at initial recognition and at subsequent measurement. Transaction costs are recognised as expenditure in the statement of financial activities as incurred.
Derecognition of financial liabilities
The Foundation derecognises financial liabilities when, and only when, the Foundation’s obligations are discharged, cancelled or they expire.
EQUIPMENT – Equipment is stated at cost less accumulated depreciation and impairment losses. Low value assets costing less than $1,000 individually are written off in the period of outlay. Cost includes expenditure that is directly attributable to the asset. Purchased software that is integral to the functionality of the related equipment is capitalised as part of that equipment. When parts of an item of plant and equipment have different useful lives, they are accounted for as separate items (major components) of plant and equipment.
The cost of replacing part of an item of equipment is recognised in the carrying amount of the item if it is probable that the future economic benefits embodied within the part will flow to the Foundation and its cost can be measured reliably. The costs of the day-to-day servicing of equipment is recognised in the statement of financial activities as incurred.
Property, plant and equipment shall not be revalued and are not required to be assessed for impairment.
Depreciation is recognised in the statement of financial activities on a straight-line basis over their estimated useful lives (or lease terms if shorter) of each part of an item of equipment as follows:
Computer equipment
3 years
Computer system
3 years
The estimated useful lives, residual values and depreciation method are reviewed at each year end, with the effect of any changes in estimate accounted for on a prospective basis.
The gain or loss arising on disposal or retirement of an item of equipment is determined as the difference between the sales proceeds and the carrying amounts of the asset and is recognised in the statement of financial activities.
GOVERNMENT GRANT – Grants from government ministry for the purchase of depreciable assets are deducted against the carrying amount of the asset in the first instance. The grant is recognised as income over the useful life of a depreciable asset by way of a reduced depreciation charge.
Fund Structure
Unrestricted fund
The unrestricted fund comprises the general fund and the designated fund. (a)
The general fund is available for use at the discretion of the Trustees in furtherance of the Foundation’s objectives. (b)
General fund
Designated fund The designated fund is available for use at the discretion of the Trustees within projects in furtherance of the Foundation’s objectives that the Trustees have identified.
SingHealth Foundation Annual Report 2012 15
NOTES TO THE FINANCIAL STATEMENTS
AS AT 31 MARCH 2013
Restricted fund
The restricted fund is available for use at the discretion of the Trustees within projects in furtherance of the Foundation’s objectives that have been identified by donors of the funds or communicated to donors when sourcing for the funds.
Income From Generated Funds (a)
Income from Generated Funds – Voluntary Income
Source of income from generated funds are usually from donations. Such donations are recognised as income when the following three criteria are met:
(i) Entitlement – normally arises when there is control over the rights or other access to the resource, enabling the Foundation to determine its future application;
(ii) Certainty – when it is virtually certain that the income will be received; and
(iii) Measurement – when the monetary value of the income can be measured with sufficient reliability.
(b)
Interest income
Interest income from fixed deposits and is recognised as it accrues, using the effective interest method.
Interest income is attributed to specific funds where these are specified by the sources of the funds. Where there are no specific agreements with donors or source of funds, interest income is attributed to the general fund.
Expenditures (a)
Charitable Activities
These are grant expenses which are recognised as they are incurred in the accounting period.
(b)
Cost of Generating Funds and Governance Costs
All fundraising and operating costs are absorbed under the general fund except for certain restricted funds and those relating to restricted funds for the Singapore General Hospital Pte Ltd, Changi General Hospital Pte Ltd and National Heart Centre of Singapore Pte Ltd which are allocated to the respective funds.
EMPLOYEE LEAVE ENTITLEMENT – Employee entitlements to annual leave are recognised when they accrue to employees. A provision is made for the estimated liability for annual leave as a result of services rendered by employees up to the end of the reporting period.
CASH AND CASH EQUIVALENTS – Cash and cash equivalents comprise cash and bank balances and bank deposits that are readily convertible to a known amount of cash and subject to an insignificant risk of changes in value.
3
CRITICAL ACCOUNTING JUDGEMENTS AND KEY SOURCES OF ESTIMATION UNCERTAINTY (i)
Critical judgements in applying the entity’s accounting policies
In the application of the Foundation’s accounting policies, which are described in Note 2, the management is required to make judgements, estimates and assumptions about the carrying amounts of assets and liabilities that are not readily apparent from other sources. The estimates and associated assumptions are based on historical experience and other factors that are considered to be relevant. Actual results may differ from these estimates.
The estimates and underlying assumptions are reviewed on an ongoing basis. Revisions to accounting estimates are recognised in the period in which the estimate is revised if the revision affects only that period, or in the period of the revision and future periods if the revision affects both current and future periods.
The management is of the opinion that any instances of application of judgements are not expected to have a significant effect on the amounts recognised in the financial statements.
(ii)
Key sources of estimation uncertainty
The assessment of recoverability of donation receivables of the Foundation is based on the on-going analysis of the outstanding receivables and on management’s estimates of the ultimate realisation of these receivables. Management has evaluated the recoverability of the receivables based on such estimates and is confident that no allowance for doubtful debts is necessary (Note 8).
16 SingHealth Foundation Annual Report 2012
NOTES TO THE FINANCIAL STATEMENTS
AS AT 31 MARCH 2013 4
FINANCIAL INSTRUMENTS, FINANCIAL RISKS AND CAPITAL RISKS MANAGEMENT
The following table sets out the financial instruments as at the end of the reporting period:
Financial assets Receivables (including cash and cash equivalents) Financial liabilities Trade and Other Payables (i) (ii)
2013
2012
$
$
165,349,779
181,406,146
7,090,511
17,132,991
Foreign currency risk management The financial assets and financial liabilities of the Foundation are denominated in Singapore dollars. The Foundation has no significant exposure to foreign currency risk. Interest rate risk management
The Foundation is exposed to market risk for changes in interest rates related primarily to fixed deposits with financial institutions. The Foundation manages its interest rate risk by placing such balances on varying maturities and interest rate terms.
Interest rate sensitivity
The sensitivity analyses below have been determined based on the exposure to interest rates for financial instruments at the balance sheet date and the stipulated change taking place at the beginning of the financial year and held constant throughout the reporting period in the case of instruments that have floating rates. A 50 basis point increase or decrease is used when reporting interest rate risk internally to key management personnel and represents management’s assessment of the possible change in interest rates.
If interest rates had been 50 basis points higher or lower and all other variables were held constant, the Foundation’s income for the year ended 31 March 2013 would increase/decrease by $589,641 (2012 : increase/decrease the income for the year by $683,794).
(iii)
(iv)
Credit risk management Credit risk is the risk of financial loss to the Foundation if a donor or a counterparty to a financial instrument fails to meet its contractual obligations, and arises principally from the Foundation’s donations receivables and cash and bank balances. Liquidity risk management
Liquidity risk is the risk that the Foundation will not be able to meet its financial obligations as they fall due. The Board of Trustees monitors the liquidity risk and maintains a level of cash and cash equivalents deemed adequate by the Board of Trustees to finance the Foundation’s operations and to mitigate the effects of fluctuations in cash flows.
The carrying amount of the trade and other payables approximates the expected contractual cash flows which will mature within the next one year.
5
RELATED PARTIES
For the purposes of these financial statements, parties are considered to be related to the Foundation if the Foundation has the ability, directly or indirectly, to control the party or exercise significant influence over the party in making financial and operating decisions, or vice versa, or where the Foundation and the party are subject to common control or common significant influence. Related parties may be individuals or other entities.
The Foundation considers Singapore Health Services Pte Ltd and its subsidiaries as related parties.
SingHealth Foundation Annual Report 2012 17
NOTES TO THE FINANCIAL STATEMENTS
AS AT 31 MARCH 2013
Other than disclosed elsewhere in the financial statements, the transactions with related parties are as follows:
Donation income received/receivable Grant expense paid/payable Manpower services received Other services received Rental and maintenance expenses Service fee income
2013
2012
$
$
(13,351,076) 17,075,144 510,523 5,393 142,614 (68,000)
(19,938,294) 23,827,615 717,648 5,393 136,982 –
Compensation of key management personnel
Key management personnel of the Foundation are those persons having the authority and responsibility for planning, directing and controlling the activities of the Foundation. The Board of Trustees is considered as key management personnel of the Foundation. The Board of Trustees did not receive any form of remuneration during the financial year.
6 EQUIPMENT Computer equipment
Computer system
Total
$
$
$
Cost: At 1 April 2011 Additions Grant received
23,724 1,015 –
112,134 – (60,940)
135,858 1,015 (60,940)
At 31 March 2012 Additions Grant received
24,739 – –
51,194 – –
75,933 – –
24,739
51,194
75,933
Accumulated depreciation: At 1 April 2011 Depreciation charge for the year At 31 March 2012 Depreciation charge for the year
18,760 2,709 21,469 2,329
3,115 24,769 27,884 12,161
21,875 27,478 49,353 14,490
At 31 March 2013
23,798
40,045
63,843
Carrying amount: At 31 March 2012
3,270
23,310
26,580
941
11,149
12,090
2013
2012
$
$
12,399,321 117,928,110
5,073,312 136,758,764
130,327,431
141,832,076
7
At 31 March 2013
At 31 March 2013
CASH AND CASH EQUIVALENTS
Cash at bank Fixed deposits with financial institutions
18 SingHealth Foundation Annual Report 2012
NOTES TO THE FINANCIAL STATEMENTS
AS AT 31 MARCH 2013
The effective interest rates per annum at the reporting date are as follows: 2013
2012
%
%
0.71
0.57
2013
2012
$
$
Donations receivable
34,684,595
39,286,774
Current
10,684,595
5,286,774
Non-current
24,000,000
34,000,000
34,684,595
39,286,774
Fixed deposits
Interest rates for fixed deposits reprice at intervals of three to nine months.
8
DONATIONS RECEIVABLE
Donations receivable relates to donations pledged by Singapore Health Services Pte Ltd and its subsidiaries.
The donations receivable includes restricted donation for talent development of $684,595 (2012 : $4,251,364) and donation restricted for specific Research and Education programmes of $34,000,000 (2012 : $34,150,000) and general donation of $Nil (2012 : $885,410).
Concentration of credit risk relating to donations receivable is high due to the small number of donors. However, Singapore Health Services Pte Ltd and its subsidiaries are highly regarded government institutions. There have been no instances of default in the collection of donations receivables. Due to these factors, management believes that no credit risk is inherent in the Foundation’s donations receivable. There is no allowance for doubtful debts arising from the outstanding balances.
The ageing of donations receivable from date of the pledge at the reporting date is as follows: GROSS
<1 year 1 year to 2 years 2 years to 3 years > 3 years
9
2013
2012
$
$
10,684,595 – – 24,000,000
885,410 2,214,395 2,186,969 34,000,000
34,684,595
39,286,774
2013
2012
$
$
307,143 30,610
287,296 –
337,753
287,296
OTHER RECEIVABLES
Interest receivable Other receivable
SingHealth Foundation Annual Report 2012 19
NOTES TO THE FINANCIAL STATEMENTS
AS AT 31 MARCH 2013
10 TRADE AND OTHER PAYABLES
Trade payables Accrued expenses Grant payables
2013
2012
$
$
488
1,851
173,108
244,990
6,916,915
16,886,150
7,090,511
17,132,991
2013
2012
$
$
124,002,535
131,074,668
34,268,823
33,225,067
158,271,358
164,299,735
11 FUNDS OF THE FOUNDATION
(i)
Restricted funds
(ii)
Unrestricted funds
(i)
(ii)
Restricted funds Restricted funds comprise earmarked funds of $124,002,535 (2012 : $131,074,668) that are required to be used for particular purposes within the Foundation’s objectives. Included in the restricted funds are funds earmarked for Singapore General Hospital, National Heart Centre and specific Research, Education and Patient Care programmes. The earmarked funds will be expended and utilised by the Foundation as and when the Foundation is satisfied that the requests for use of funds are in keeping with donors’ intents and that the terms and conditions imposed upon the organisation making the claims for these particular purposes are met. As at 31 March 2013, $46,232,508 (2012 : $32,739,400) has been designated for grants and other commitments. Unrestricted funds Unrestricted funds are funds that are expendable at the full discretion of the Trustees in furtherance of the Foundation’s objectives. 2013
2012
$
$
– Surplus fund for general use
20,658,511
10,327,634
– Fund designated for grants and other commitments
13,610,312
22,897,433
34,268,823
33,225,067
2013
2012
$
$
15,683,255
21,311,403
981,288
911,281
16,664,543
22,222,684
Unrestricted funds comprise:
12 VOLUNTARY INCOME
Tax deductible donations Other donations
The tax deductible donations include donation income recognised but not yet received for the year amounting to $684,595
(2012 : $885,410). These donations are tax deductible in nature.
20 SingHealth Foundation Annual Report 2012
NOTES TO THE FINANCIAL STATEMENTS
AS AT 31 MARCH 2013
13 ANNUAL DONATIONS AND COSTS OF GENERATING FUNDS 2013
2012
$
$
Donations in cash from individuals Donations received/receivable from corporations, institutions and foundations
1,416,927
1,345,357
15,247,616
20,877,327
Total donations
16,664,543
22,222,684
Direct fundraising expenses
74,613
77,174
Indirect costs
70,063
320,603
144,676
397,777
1%
2%
2013
2012
$
$
18,150,910 279,950 71,260
24,479,867 215,020 45,954
18,502,120
24,740,841
Total fundraising expenditure Fundraising efficiency ratio
14 CHARITABLE ACTIVITIES EXPENSES
Grant expense Manpower costs Other expenses
Grant expenses are generally made to institutions. They are expensed to support healthcare programmes through four core activities: Championing Cord Blood Bank, Upgrading Knowledge, Researching Possibilities, and Enhancing Care.
The breakdown is as follows:
Analysis Championing Cord Blood Bank Upgrading Knowledge Researching Possibilities Enhancing Care
2013
2012
$
$
1,075,767 5,923,102 5,612,403 5,539,638
652,252 9,841,563 11,473,132 2,512,920
18,150,910
24,479,867
2013
2012
$
$
35,176 345,741 85,513 120,414
42,000 360,057 67,595 85,008
586,844
554,660
15 GOVERNANCE COST
Audit fees Manpower costs Rental expenses Other expenses
SingHealth Foundation Annual Report 2012 21
NOTES TO THE FINANCIAL STATEMENTS
AS AT 31 MARCH 2013
16 OTHER EXPENDITURE
This comprises mainly of a distribution to Changi Health Fund (LTD) (“CHF”) of the unused balance of donations the Foundation holds that are designated for Changi General Hospital and Eastern Health Alliance. Upon distribution to CHF, the funds shall be managed and governed by the CHF Board of Directors.
17 NET INCOME (EXPENDITURE) FOR THE YEAR
The following items have been included in arriving at net expenditure: 2013
2012
$
$
Operating lease expense
144,902
140,491
Manpower costs
686,023
926,898
Contributions to defined contribution plans included in manpower costs
62,677
83,806
Depreciation of plant and equipment
14,490
27,478
18 REMUNERATION OF PERSONNEL
The number of personnel whose remuneration exceeded $50,000 during the year were as follows: 2013
2012
Number of personnel in bands:
$50,001 to $100,000
4
7
$100,001 to $150,000
1
1
$150,001 to $200,000
1
0
$200,001 to $250,000
0
1
6
9
Total
19 INCOME TAX EXPENSE
There is no tax charge for the current year as the Foundation is a registered charity with income tax exemption with effect from year of assessment 2008.
20 COMMITMENTS
The Foundation extends multi-year funding commitments relating to grant awards for 2013 to 2015.
Commitments contracted but not provided for: – Restricted funds committed – Unrestricted funds committed
2013
2012
$
$
46,232,508 13,610,312
32,739,400 22,897,433
59,842,820
55,636,833
22 SingHealth Foundation Annual Report 2012
LIST OF PROJECTS APPROVED FOR FUNDING IN FY2012 (SingHealth Foundation)
CHAMPIONING CORD BLOOD BANK
$1.1
MILLION
Since its inception in 2004, the Singapore Cord Blood Bank has attained 96% of its initial targeted inventory of 10,000 high-quality and clinically safe CBUs, with 9,681 CBUs banked in FY2012. As the only public cord blood bank in Singapore amassing Asian cord blood units, the bank aims to improve the chances of Asians worldwide finding a suitable match.
UPGRADING KNOWLEDGE
$5.3
MILLION
RESEARCHING POSSIBILITIES
SingHealth Foundation funds biomedical research endeavours that have the potential to improve patients’ lives. It invests in the continued quest for life-saving cures today for solutions that shape tomorrow’s care experience. Start-Up Projects, Health Services Research, Clinical Trials, Translational and Clinical Research Grants Funding Support for the purchase of MicroPET/ CT
$19.0 MILLION
SingHealth Foundation facilitates the ongoing training and development of our healthcare professionals through multiple programmes that nurture lifelong learning essential to upholding the highest standards of patient care. We support their professional development which is crucial to reinforce the latest advances in care delivery. Talent Development Fund FY2013
$2.5
MILLION
ENHANCING CARE
In supporting a wide array of programmes and activities, the Foundation strives to provide continuity of care holistically for patients to improve prognosis and quality of life, ensuring that their social and medical needs are met.
Supplementary Health Manpower Development Programme FY2013
Funding Specialised Equipment/systems to create a Hybrid OT for Advanced Vascular Surgery
Academic Clinical Programmes for Surgery, Ophthalmology and Neuroscience
National Dental Centre Tooth Fairy Fund
Cardiovascular Academic Clinical Programmes Training/Upgrading of Nursing Personnel FY2012
Transitional Home Medical Care Financial Assistance for needy HIV patients – Initiate Fund Financial Assistance for Patients Requiring Respiratory Equipment SingHealth Women’s Forum 2012
SingHealth Foundation Annual Report 2012 23
SingHealth Foundation manages the charitable funds of several institutions in the SingHealth cluster. New projects supported by these managed funds in FY2012 include:
UPGRADING KNOWLEDGE
RESEARCHING POSSIBILITIES
ENHANCING CARE
$2.9 MILLION
$3.8 MILLION
$1.1 MILLION
Changi General Hospital Medical Education Grants
Changi General Hospital Research Fund
Exercise is Medicine Singapore
Changi General Hospital Patient Welfare Fund HomeCare Assist Programme Mobility Programme
National Heart Centre Singapore National Heart Centre Singapore Cardiac Rehabilitation Awareness programme
Singapore General Hospital
Partnership for Personalized Medicine Singapore Cardiac Data Bank Operations Collaborative Research Study on biomarkers that associate chest pains with adverse events
National Heart Centre Singapore Patient Trust Fund for emergency relief and short term financial aid Cardiovascular Rehabilitation and Prevention Programme
Training of medical, nursing and allied health professionals in: General Surgery Emergency Medicine Neurosurgery
Singapore General Hospital Research projects in the following areas:
Singapore General Hospital Supports patient services programmes in:
Nuclear Medicine
Pathology
Burn Care Programme
Obstetrics & Gynaecology
Endocrinology
Light Weight Club
Urology
Diagnostic Radiology Otolaryngology
Haematopoietic Stem Cell Transplant
Gastroenterology
Interim Dialysis
Haematology
Music Therapy
General Surgery
Robotic Assisted Laparoscopic Surgery
Urology
24 SingHealth Foundation Annual Report 2012
PROGRAMME HIGHLIGHTS FOR FY2012
Since 2004, more than
9,600 CBUs BANKED
OVER 990 searches conducted
Out of 3,858 CBUs collected in FY2012,
1,450 MET BANKING CRITERIA
CHAMPIONING CORD BLOOD BANK During the year, 25 transplants (14 local, 1 regional and 10 international) were facilitated, bringing the total to 126 transplants (49 paediatric and 77 adult) facilitated since inception. Other than Singapore, SCBB facilitated cord blood transplants in Malaysia, Canada, France, England, Italy and the USA last year.
With declining births a real concern, SCBB continued its focus on education and outreach to the public and healthcare community to increase awareness of its cause, so as to increase cord blood donations and grow its bank of high-quality clinical CBUs.
33 main programmes
INCLUDING 7 APPROVED IN FY2012
UPGRADING KNOWLEDGE
These programmes include the Talent Development Fund, which builds the capabilities of SingHealth VIA MORE THAN human capital to support 300 FORMAL AND SingHealth’s strategic focuses; NON-FORMAL Supplementary Health PROGRAMMES Manpower Development programmes aimed at developing SingHealth’s health manpower capabilities to meet evolving national healthcare needs; and Training/Upgrading of Nursing Personnel programmes that tapped on earmarked funds from Lee Foundation to level up nurses’ knowledge and education, enabling them to take on leadership roles.
Over 6,000 healthcare personnel trained
RESEARCHING POSSIBILITIES
16 PROJECT-BASED PROJECTS 12 START-UPS SERVICES 4 HEALTH RESEARCH 3CLINICAL TRIAL GRANTS
One of the objectives of the Foundation’s research grants is to increase SingHealth’s scientific capabilities which lead to medical innovation and awarded in FY2012 better patient care through INCLUDES MULTI-YEAR knowledge and research PROGRAMMES STRETCHING findings (e.g. publications, FROM FY2012 TO FY2015 patents). The quality of publications has increased steadily over the past years. In addition, two patents were submitted on the high refractive index polymer technology used in developing the Cornea Hydrogel lens implant for correction of refractive errors. Future possibilities of this technology and commercial collaborations are being explored. Another objective is to support and nurture young and budding clinicians and investigators in their quest to compete for national competitive grants. Research funding from various sources has reached a total of $888m in the past 12 years. More than 20% of investigators who received Foundation grants received national grants.
ENHANCING CARE
7
new programmes approved in FY2012
BENEFITTING MORE THAN
2,000
Besides benefitting patients through innovative medical solutions and financial support, the programmes we support also meet the needs from the Total of public at national level. In line 27 active with the national strategy, programmes the Foundation approved NOW SUPPORTED $8m for the Transformation, Redevelopment and Reorganisation of SingHealth Polyclinics – Bedok, Geylang and Tampines – as part of the Eastern Integrated Regional Health System/Eastern Health Alliance to provide primary, secondary and step down care in an integrated health services model. As part of this programme, SingHealth Geylang polyclinic underwent renovation and reopened in December 2012.
PATIENTS
DONORS, PARTNERS AND SUPPORTERS Our heartfelt thanks go to the donors, partners and supporters of SingHealth Foundation and Integrated Funds (Changi General Hospital, Singapore General Hospital and National Heart Centre Singapore).
$500,000 & Above
$50,000 to $499,999
Lee Foundation Singapore Health Services Pte Ltd
Lum Ooi Lin Ng Wei Yong Transmedic Pte Ltd
$10,000 to $49,999
$5,000 to $9,999
Choo Chiau Beng
Leng Poey Yoke Catherine
Dr Sim Wee Kiat, PBM, PBS
Lim Yin Nee Jenny
DS Lee Foundation
Low Kheng Choong Agnes
Far East Organization
NTUC FairPrice Foundation
Hitachi Data Systems Pte Ltd
Ong Mun Teng
Hwang Soo Jin
PSA International Ltd
ISS Facility Services Pte Ltd
Sembcorp Industries Ltd
In memory of Mr & Mrs Tham Poh Leong
Sentosa Golf Club
In memory of Mr Robert Wee Sian Guan
Singapore Totalisator Board
Keppel Corporation Ltd
Tan Siew Ooa
Khoo Linda
Toh Kim Choon
Lee Yok Eng
TTJ Design & Engineering Pte Ltd
Allen & Gledhill LLP
Lim Yue-Li
Bank Julius Baer
Low Si Ren Kenneth
Bengawan Solo Pte Ltd
Mellford Pte Ltd
City Developments Limited
Ngee Ann Kongsi
DBS Bank Ltd
Ong Siew Ching
Deutsche Bank Private Wealth Management
Ong Yaw Hwee
Fortis Healthcare International Pte Ltd
Poh Lian Construction Pte Ltd
Great Eastern Life Assurance Co Ltd
Pontiac Land Group
Harry Elias Partnership LLP
Seah Seow Hor
Hong Leong Foundation
SPH Magazines Pte Ltd
Interlocal Exim Pte Ltd
The Fullerton Hotel Singapore
Kajima Overseas Asia Pte Ltd
Toshiba Medical Systems Pte Ltd
Kopitiam Investment Pte Ltd
Wisanggeni Lauw
Kurihara Kogyo Co Ltd
Zimmer Pte Ltd
167 Jalan Bukit Merah Tower 5 #22-10A Singapore 150167 e: foundation@singhealth.com.sg w: www.singhealthfoundation.org.sg UEN T02CC1576B MOH Account Registration No HEF0074/G